Westfield Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $702K | Buy |
|
|||||
|
2024
Q3 | $592K | Buy |
|
|||||
|
2024
Q2 | $255K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $154M | Buy |
|
|||||
|
2020
Q3 | $162M | Buy |
|
|||||
|
2020
Q2 | $155M | Sell |
|
|||||
|
2020
Q1 | $149M | Sell |
|
|||||
|
2019
Q4 | $157M | Sell |
|
|||||
|
2019
Q3 | $158M | Buy |
|
|||||
|
2019
Q2 | $145M | Buy |
|
|||||
|
2019
Q1 | $125M | Buy |
|
|||||
|
2018
Q4 | $107M | Buy |
|
|||||
|
2018
Q3 | $106M | Sell |
|
|||||
|
2018
Q2 | $148M | Buy |
|
|||||
|
2018
Q1 | $127M | Buy |
|
|||||
|
2017
Q4 | $92.7M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $38.9M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $566K | Sell |
|
|||||
|
2015
Q3 | $204M | Buy |
|
|||||
|
2015
Q2 | $26.1M | Buy |
|
|||||
|
2015
Q1 | $20.6M | Sell |
|
|||||
|
2014
Q4 | $33.8M | Sell |
|
|||||
|
2014
Q3 | $32.4M | Buy |
|